A Phase 1, Open-Label, Fixed-Sequence, Crossover Study to Evaluate the Interaction of Multiple-Dose Odevixibat with the Pharmacokinetics of Single-Dose Combined Oral Contraceptive Steroids in Healthy Female Participants
Latest Information Update: 03 Jun 2025
At a glance
- Drugs Odevixibat (Primary) ; Ethinylestradiol; Levonorgestrel
- Indications Alagille syndrome; Biliary atresia; Cholestasis; Intrahepatic cholestasis
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 03 Jun 2025 New trial record